— Know what they know.
Not Investment Advice
Also trades as: RCO.PA (PAR) · $vol 3M · REMYY (OTC) · $vol 0M

REMYF OTC

Rémy Cointreau S.A.
1W: -4.1% 1M: -8.6% 3M: -1.0% YTD: +19.4% 1Y: -17.1% 3Y: -67.4% 5Y: -71.6%
$54.31
+2.18 (+4.18%)
 
OTC · Consumer Defensive · Beverages - Wineries & Distilleries · Tech Score Sell · Power 41 · $2.6B mcap · 21M float · 0.0025% daily turnover · Short 82% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.6B
52W Range40.01-56.8
Volume500
Avg Volume531
Beta0.73
Dividend$0.85
Analyst Ratings
1 Buy 2 Hold 0 Sell
Consensus Hold
Company Info
CEOFranck Marilly
Employees1,783
SectorConsumer Defensive
IndustryBeverages - Wineries & Distilleries
IPO Date2010-10-15
rue Joseph Pataa
Cognac, NA 16100
FR
+33 1 44 13 44 13
About Rémy Cointreau S.A.

Rémy Cointreau S.A., operating with its various subsidiary companies, is a global enterprise focused on the creation, marketing, and international supply of a diverse array of fine liqueurs and spirits. Its business activities are structured into key divisions: Rémy Martin, Liqueurs & Spirits, and Partner Brands. The firm's comprehensive product line features a selection of premium alcoholic beverages, including various liqueurs, brandy, gin, exceptional single malt whiskies, rum, choice wines, and champagne. These offerings are primarily showcased under renowned labels such as Cointreau, Metaxa, St-Rémy, Mount Gay, Bruichladdich, Port Charlotte, Octomore, The Botanist, Westland, LOUIS XIII, and Domaine des Hautes Glaces. With a significant worldwide reach, Rémy Cointreau's market presence extends across Europe, the Middle East, Africa, the Americas, Asia, Australia, and New Zealand. The company was founded in 1724 and its primary corporate office is situated in Cognac, France.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms